高盛下調離岸中國股市投資評級 惟續看好A股
高盛下調對中國離岸股市的投資評級,把MSCI中國指數評級「增持」降至「與大市同步」,直指指數內科技及民企股不符比例的高佔比,促使有關下調。高盛同時重申對中國A股的「增持」評級,基於中國A股對下半年潛在財政政策寬鬆更具敏感度,且在政策強力支援領域權重較高,及有強勁的買入潛力。
高盛指,近期內地監管行動,顯示相比資本市場,當局更看重被視爲公衆利益或對策略性政策目標重要的社會公平及穩定。該行認爲,中國科技企業或民企目前估值吸引,然而目前判斷股市價格及情緒週期出現轉折點言之過早,基於投資者作出估值時仍繼續由監管問題主導。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.